Krystle Vermes

The US Marshals Service recently seized more than 100 cases of products containing the opioid-like botanical substance.

Teva is recalling 7 lots of its amikacin sulfate injection and vials because of the potential presence of glass particulate matter.

The FDA has issued draft guidance for compounders outlining insanitary conditions that put patients at risk for harm.

Teva's generic equivalent of Novartis's Gleevec is now available in the US market.

Just in time for the 2016-2017 flu season, the FDA has approved the first generic version of oseltamivir phosphate (Tamiflu).

Mylan's generic version of Dexedrine is now available at US pharmacies in 3 dosage strengths.

The FDA has approved Silvergate Pharmaceuticals' Qbrelis, the first lisinopril oral solution.

Shire's investigational SHP626 (volixibat) treatment for nonalcoholic steatohepatitis with liver fibrosis has just received fast track designation from the FDA.

CareFusion is recalling its AVEA ventilator because of an electrical issue on the product's alarm board that may cause it to shut down unexpectedly.

Baxter's DoseEdge Pharmacy Workflow Manager has detected more than 3 million potential medication preparation errors prior to drugs being administered to patients.

Mylan recently announced that it has launched a generic version of Crestor (rosuvastatin calcium) tablets in 5mg, 10mg, 20mg, and 40mg dosage strengths.

Texas-based Talon Compounding Pharmacy (TCP) recently issued a voluntary recall of all lots of lyophilized HCG and sermorelin amid FDA concerns about sterility assurance.

The FDA has approved an expanded indication for type 2 diabetes treatment Synjardy (empagliflozin and metformin hydrochloride) to include treatment-naïve adults. Synjardy is designed to improve glycemic control in adults with type 2 diabetes.

The FDA has approved an expanded label for memantine and donepezil hydrochlorides (Namzaric) extended-release, a once-daily, fixed-dose combination of a NMDA receptor agonist and an acetylcholinesterase inhibitor.

The FDA reviews Medicure Inc’s supplemental new drug application for Aggrastat.

The FDA has approved Abbott's Tecnis Symfony Intraocular Lenses for the treatment of cataracts.

PharmTech LLC is voluntarily recalling all lots of Diocto Liquid, which is a docusate sodium solution distributed by Rugby Laboratories.

Mylan has launched a generic version of Merck's Temodar capsules, which may be used to treat patients with newly diagnosed cancerous tumors known as glioblastoma multiforme concomitantly with radiotherapy, then as maintenance treatment.

Systemic sclerosis affects the connective tissue of the skin and internal organs.

iBio-CFB03 is an anti-fibrotic agent based on a plant-made protein for the treatment of systemic sclerosis.

The FDA has granted Orphan Drug Designation to iBio-CFB03, an investigational biotherapeutic product intended to treat systemic sclerosis.

The FDA has approved a dedicated syringe for Humulin R U-500 insulin, eliminating the need for dose conversions for patients who previously used U-100 tuberculin syringes.

The FDA has approved Differin Gel 0.1% for OTC use.

Idalopirdine is a selective 5HT6 receptor antagonist with a different mechanism of action than current Alzheimer’s medications.

The FDA has granted fast-track designation to Lundbeck and Otsuka's idalopirdine, an investigational treatment for mild to moderate Alzheimer's disease.

Syndros treats anorexia related to AIDS and cancer patients experiencing nausea and vomiting due to chemotherapy.

Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.

The FDA has approved Insys Therapeutics Inc's oral solution, Syndros, which is a liquid formulation of the pharmaceutical cannabinoid dronabinol.

Dream Body Weight Loss is voluntarily recalling several of its products due to undeclared sibutramine.

The FDA has granted marketing approval to Cepheid's Xpert Carba-R Assay, an infection control aid that tests patient specimens for specific genetic markers linked with bacteria that are resistant to Carbapenem antibiotics.